Surprisingly rapid regrowth of unused brain connections after decades of near blindness
Since 2007, clinical trials using gene therapy have resulted in often-dramatic sight restoration for dozens of children and adults who were otherwise doomed to blindness. Now, researchers from the Perelman School of Medicine at the University of Pennsylvania and The Children’s Hospital of Philadelphia (CHOP), have found evidence that this sight restoration leads to strengthening of visual pathways in the brain, published this week in Science Translational Medicine.
“The patients had received the gene therapy in just one eye (their worse seeing eye), and though we imaged their brains only about two years later, on average, we saw big differences between the side of the brain connected to the treated region of the injected eye and the side connected to the untreated eye,” said lead author Manzar Ashtari, PhD, director of CNS Imaging at the Center for Advanced Retinal and Ocular Therapeutics in the Department of Ophthalmology at Penn. Ashtari is the former director of Diffusion Tensor Image Analyses and Brain Morphometry at CHOP.
“It’s an elegant demonstration that these visual processing pathways can be restored even long after the period when it was thought there would be a loss of plasticity,” said senior author Jean Bennett, MD, PhD, the F.M. Kirby Professor of Ophthalmology at Penn and director of the Center for Advanced Retinal and Ocular Therapeutics.
The team examined ten patients who have Leber’s congenital amaurosis Type 2 (LCA2), a rare disease that afflicts those who inherit a bad copy of an LCA2 gene from each parent, LCA2 causes their retinas to degenerate slowly and they typically have limited visual function at birth and then experience progressive loss of their remaining vision, rendering them completely blind by mid-life.
In one of the first great success stories for gene therapy, Bennett’s team and others demonstrated the effectiveness of LCA2 gene augmentation in animal tests stretching back to the early 2000s. The basic strategy is to inject a harmless virus that inserts good copies of the normal LCA2 gene into retinal cells. Patients who have received the gene therapy have commonly gone from being blind or near blind to being partially sighted and able to navigate almost normally.
One question hanging over the field has been: even if retinal function improves, how well can the brain’s visual processing pathways recover, after years of near-total blindness in which those unused pathways inevitably will have weakened?
Ashtari, a neuroimaging specialist, addressed this question with several experiments. First she compared the LCA2 group, which had initially received the gene therapy in one eye for safety reasons, to an age-matched control group with normal vision.
Using an advanced method of MRI technique to uncover deep brain connections, she found that while the connectivity of the visual pathway from the treated eye in LCA2 patients was similar to that of sighted controls, the untreated eye showed weaker connectivity to the brain as compared to the connections for the treated side. The data showed that the retina-brain pathways in the treated eyes in the LCA2 group seemed nearly as robust as the corresponding pathways in the sighted control group, implying that these pathways had largely rebuilt themselves in the LCA2 patients, following their retinal intervention.
“That was what we expected to see— the more the treated eye sees the world and interacts with the environment the more it stimulates the pathway and the stronger the connecting pathway becomes between the retina and the brain,” said Ashtari.
The result came despite the fact that many of the LCA2 patients were in their 20s, and one was even 45—an age when the ability of the nervous system to rewire itself is thought to be greatly reduced.
Ashtari also found a strong hint in the data that the treated-eye pathways tended to be in better shape when more time had elapsed since the treatment, implying that these pathways continue to improve with use. By contrast, the untreated-eye pathways showed a clear decline with time.
The Latest on: Vision-Restoring Gene Therapy
[google_news title=”” keyword=”Vision-Restoring Gene Therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Vision-Restoring Gene Therapy
- Adverum Biotechnologies to Participate in Upcoming May Investor Conferenceson May 3, 2024 at 5:41 am
H.C. Wainwright 2nd Annual BioConnect Investor Conference on Monday, May 20, 2024 at 11:00 a.m. ET. The on-demand webcast of the panel discussion may be accessed under Events and Presentations in the ...
- Nanoscope Therapeutics: Gene Therapy Improves Visual Acuity in Patients with Retinitis Pigmentosaon April 30, 2024 at 5:30 am
Gene therapy demonstrated clinically meaningful vision improvement in legally blind individuals. The therapy is capable of restoring vision even in advanced disease stages. The Latest A recent ...
- CIRM awards $31 million to fund clinical-stage research for cancers and eye diseaseon April 26, 2024 at 8:39 am
South San Francisco, CA, April 26, 2024 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has approved awarding ...
- Restoring sight is possible now with optogeneticson April 22, 2024 at 11:30 pm
(Carolyn Fong for The Washington Post) Therapeutic optogenetic therapy for vision restoration certainly has ... Its method involves a gene-therapy vector that transfers an opsin called Chronos ...
- Why There’s New Hope About Ending Blindnesson July 18, 2023 at 8:16 am
His vision, already bad ... When assessing the sight-restoring potential of gene therapy, stem cells, and retinal implants, it’s fair to view them as a sort of three-legged stool.
- First Ever Topical Gene Therapy Approved For “Butterfly Disease” Childrenon May 24, 2023 at 3:29 am
Patients with dystrophic EB disorder suffer from open wounds, causing skin infections and are at an increased risk of vision loss ... (HSV-1)–based gene therapy designed to restore C7 protein ...
- The Bionic Eye That Could Restore Vision (and Put Humans in the Matrix)on May 17, 2023 at 5:30 pm
It's a device he hopes can restore a critical sense and help the blind see again. It doesn't look like much — a miniature city of electronics attached to a microLED display just 2mm square ...
- Gene Therapyon December 12, 2021 at 6:50 pm
2007). These findings suggested that gene therapy might restore some functional vision to people with LCA, and they therefore served as encouragement to scientists and doctors planning human gene ...
- Seeking Enlightenment: The Quest To Restore Vision In Humanson December 29, 2020 at 4:48 am
More recently, the possibility of restoring ... injury-induced vision loss through epigenetic reprogramming (bioRxiv preprint version). Obviously, the goal in this kind of gene therapy to erase ...
- Marina Gorbatyuk, PhDon April 9, 2018 at 11:55 pm
I have been working on designing a gene therapy targeting different mutations within ... Alabama at Birmingham as an associate professor where I continue my work on vision restoration. Research in my ...
via Bing News